改良DOC联合DDP和5-FU一线治疗晚期胃癌及胃食管结合部癌的临床观察Modified DCF regimen as first-line chemotherapy for patients with advanced gastric and esophago-gastric junction cancer
郑鸿,祝子华,张宁,肖迷
摘要(Abstract):
目的探讨多西他赛(docetaxel,DOC)联合顺铂(DDP)和5-氟尿嘧啶(5-FU)一线治疗晚期胃癌和胃食管结合部癌的临床疗效和不良反应。方法回顾性分析80例晚期胃癌及胃食管结合部癌患者,接受改良双周DCF方案化疗;具体为多西他赛37.5 mg/m2第1、8天静脉滴注;顺铂20 mg/m2第1-2、8-9天静脉滴注;5-氟尿嘧啶1.0 g/m2第1、8天用药,每次微泵持续静脉滴注48小时,21天为1周期,治疗≥2周期,分析其疗效和不良反应。结果 78例患者接受平均4.7周期(2-11周期)的改良双周DCF方案的化疗,均无化疗相关性死亡,总有效率为35.9%(28/78);疾病控制率为78.2%(61/78),中位疾病进展时间为5.0月(95%CI:4.3-5.7月),中位生存时间8.9月(95%CI:6.8-11.0月);1年的生存率33.3%(26/78)。结论对于不能耐受3周方案的晚期胃癌及胃食管结合部癌患者,采用改良双周DCF方案一线治疗疗效肯定且不良反应可耐受,值得临床进一步应用。
关键词(KeyWords): 胃肿瘤/药物疗法;氟尿嘧啶/投药和剂量;抗肿瘤联合化疗方案/治疗应用;顺铂/投药和剂量;治疗结果;紫杉烷类/投药和剂量;食管肿瘤/药物疗法;回顾性研究
基金项目(Foundation):
作者(Author): 郑鸿,祝子华,张宁,肖迷
DOI: 10.13267/j.cnki.syzlzz.2014.04.043
参考文献(References):
- [1]Horner MJ,Ries LAG,Krapcho M,et al.SEER cancer statistics review,1975-2006.National Cancer Institute[EB/OL](2008-10)[2009-05].http://seer.cancer.gov/csr/1975_2006/.
- [2]Van Cutsem E,Moiseyenko V,Tjulandin S,et al.PhaseⅢstudy of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapyFor advanced gastric cancer:a report of the V325Study Group[J].J Clin Oncol,2006,24(31):4991-4997.
- [3]Ajani JA.Docetaxel in combination for advanced gastric cancer[J].Gastric Cancer,2002,5(Suppl 1):31-34.
- [4]Edge S,Byrd DR,Compton CC,et al.AJCC cancer staging manual[M].7thed.New York:Springer-Verlag New York Inc,2010:11.
- [5]李进.肿瘤内科诊治策略[M].第2版.上海:上海科学技术出版社,2010:284.
- [6]周际昌.实用肿瘤内科学[M].第1版.北京:北京科技出版社,2010:445.
- [7]Rahman KM,Banerjee S,Ali S,et al.3,3'-Diindolylmethanenhances taxotere-induced apoptosis in hormonerefractory rostate cancer cells through survivin down-regulation[J].Cancer Res,2009,69(10):4468-4475.
- [8]常顺伍.紫杉醇联合卡培他滨治疗复发转移性胃癌临床疗效分析[J].实用肿瘤杂志,2013,28(1):68-70.
- [9]沈预程,储建华.周剂量多西紫杉醇联合小剂量顺铂、5-氟尿嘧啶持续静脉滴注治疗晚期胃癌的疗效观察[J].肿瘤基础与临床,2009,22(4):318-320.
- [10]施学辉,樊永茹,姚海蓉.多西他赛联合顺铂、氟尿嘧啶治疗进展期胃癌近期疗效观察[J].实用肿瘤杂志,2008,23(3):264-265.
- [11]Nakamura Y,Kunit oh H,Kubota K,et al.Retrospective analysis of safety and efficacy of low-dose docetaxel 60mg/m2in advanced non-small cell lung cancer patients previously treated with platinum based chemotherapy[J].Am J Clin Oncol,2007,26(5):459-464.
- [12]Overman MJ,Kazmi SM,Jhamb J,et al.Weekly docetaxel,cisplatin,and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer[J].Cancer,2010,116(6):1446-1453.